Cargando…

How to develop a meaningful radiomic signature for clinical use in oncologic patients

During the last decade, there is an increasing usage of quantitative methods in Radiology in an effort to reduce the diagnostic variability associated with a subjective manner of radiological interpretation. Combined approaches where visual assessment made by the radiologist is augmented by quantita...

Descripción completa

Detalles Bibliográficos
Autores principales: Papanikolaou, Nikolaos, Matos, Celso, Koh, Dow Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195800/
https://www.ncbi.nlm.nih.gov/pubmed/32357923
http://dx.doi.org/10.1186/s40644-020-00311-4
_version_ 1783528613071552512
author Papanikolaou, Nikolaos
Matos, Celso
Koh, Dow Mu
author_facet Papanikolaou, Nikolaos
Matos, Celso
Koh, Dow Mu
author_sort Papanikolaou, Nikolaos
collection PubMed
description During the last decade, there is an increasing usage of quantitative methods in Radiology in an effort to reduce the diagnostic variability associated with a subjective manner of radiological interpretation. Combined approaches where visual assessment made by the radiologist is augmented by quantitative imaging biomarkers are gaining attention. Advances in machine learning resulted in the rise of radiomics that is a new methodology referring to the extraction of quantitative information from medical images. Radiomics are based on the development of computational models, referred to as “Radiomic Signatures”, trying to address either unmet clinical needs, mostly in the field of oncologic imaging, or to compare radiomics performance with that of radiologists. However, to explore this new technology, initial publications did not consider best practices in the field of machine learning resulting in publications with questionable clinical value. In this paper, our effort was concentrated on how to avoid methodological mistakes and consider critical issues in the workflow of the development of clinically meaningful radiomic signatures.
format Online
Article
Text
id pubmed-7195800
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71958002020-05-06 How to develop a meaningful radiomic signature for clinical use in oncologic patients Papanikolaou, Nikolaos Matos, Celso Koh, Dow Mu Cancer Imaging Review During the last decade, there is an increasing usage of quantitative methods in Radiology in an effort to reduce the diagnostic variability associated with a subjective manner of radiological interpretation. Combined approaches where visual assessment made by the radiologist is augmented by quantitative imaging biomarkers are gaining attention. Advances in machine learning resulted in the rise of radiomics that is a new methodology referring to the extraction of quantitative information from medical images. Radiomics are based on the development of computational models, referred to as “Radiomic Signatures”, trying to address either unmet clinical needs, mostly in the field of oncologic imaging, or to compare radiomics performance with that of radiologists. However, to explore this new technology, initial publications did not consider best practices in the field of machine learning resulting in publications with questionable clinical value. In this paper, our effort was concentrated on how to avoid methodological mistakes and consider critical issues in the workflow of the development of clinically meaningful radiomic signatures. BioMed Central 2020-05-01 /pmc/articles/PMC7195800/ /pubmed/32357923 http://dx.doi.org/10.1186/s40644-020-00311-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Papanikolaou, Nikolaos
Matos, Celso
Koh, Dow Mu
How to develop a meaningful radiomic signature for clinical use in oncologic patients
title How to develop a meaningful radiomic signature for clinical use in oncologic patients
title_full How to develop a meaningful radiomic signature for clinical use in oncologic patients
title_fullStr How to develop a meaningful radiomic signature for clinical use in oncologic patients
title_full_unstemmed How to develop a meaningful radiomic signature for clinical use in oncologic patients
title_short How to develop a meaningful radiomic signature for clinical use in oncologic patients
title_sort how to develop a meaningful radiomic signature for clinical use in oncologic patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195800/
https://www.ncbi.nlm.nih.gov/pubmed/32357923
http://dx.doi.org/10.1186/s40644-020-00311-4
work_keys_str_mv AT papanikolaounikolaos howtodevelopameaningfulradiomicsignatureforclinicaluseinoncologicpatients
AT matoscelso howtodevelopameaningfulradiomicsignatureforclinicaluseinoncologicpatients
AT kohdowmu howtodevelopameaningfulradiomicsignatureforclinicaluseinoncologicpatients